Portal vein thrombosis, livedo reticularis, polymicrobial sepsis and high antiphospholipid antibody titers in a newborn: A clinicopathological conference of antiphospholipid-associated neonatal syndrome

Lupus. 2021 Jan;30(1):141-148. doi: 10.1177/0961203320967418. Epub 2020 Oct 22.

Abstract

Neonatal Antiphospholipid syndrome (APS) is a rare disease related to transplacental passage of antiphospholipid (aPL) antibodies from the mother or de novo production of aPL in a newborn. Neonatal aPL antibodies have rarely been associated with thrombosis. We describe a 5-week-old infant who developed fever, portal vein thrombosis and livedo reticularis like skin rash. Evaluation for thrombosis revealed high titers of antiphospholipid (aPL) antibodies (dual positive) in the child without any evidence of aPL antibodies in the mother, suggesting a de novo production in the child. Autopsy findings revealed umbilical vein sepsis with thrombosis of portal vein secondary to gram positive cocci which led to multiple liver and lung abscesses. Additionally, the baby had disseminated Cytomegalovirus (CMV) disease (acquired postnatally) involving walls of umbilical and portal vein, liver, lungs, adrenals, pancreas, thymus, and kidneys. Our case highlights the need for testing of aPL in every neonate with arterial or venous thrombosis even when the mother may have no features suggestive of an autoimmune disease.

Keywords: Neonatal antiphospholipid syndrome; antiphospholipid antibody titers; autopsy; neonate; portal vein thrombosis.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Antiphospholipid / blood*
  • Antiphospholipid Syndrome / immunology*
  • Antiphospholipid Syndrome / pathology
  • Autopsy
  • Fatal Outcome
  • Female
  • Humans
  • Infant, Newborn
  • Livedo Reticularis / immunology*
  • Livedo Reticularis / pathology
  • Portal Vein
  • Sepsis / pathology
  • Venous Thrombosis / immunology*
  • Venous Thrombosis / pathology

Substances

  • Antibodies, Antiphospholipid